Pharmaceutical Industry and Public Policy in Post-reform India: Critical Political Economy of South Asia
Autor Reji K. Josephen Limba Engleză Paperback – 28 noi 2017
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 323.49 lei 43-57 zile | |
Taylor & Francis – 28 noi 2017 | 323.49 lei 43-57 zile | |
Hardback (1) | 814.38 lei 43-57 zile | |
Taylor & Francis – 4 aug 2015 | 814.38 lei 43-57 zile |
Preț: 323.49 lei
Preț vechi: 371.69 lei
-13% Nou
Puncte Express: 485
Preț estimativ în valută:
61.92€ • 64.53$ • 51.54£
61.92€ • 64.53$ • 51.54£
Carte tipărită la comandă
Livrare economică 06-20 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780815375999
ISBN-10: 0815375999
Pagini: 252
Ilustrații: 14 Line drawings, black and white; 33 Tables, black and white; 14 Illustrations, black and white
Dimensiuni: 138 x 216 x 13 mm
Greutate: 0.45 kg
Ediția:1
Editura: Taylor & Francis
Colecția Routledge India
Seria Critical Political Economy of South Asia
Locul publicării:Oxford, United Kingdom
ISBN-10: 0815375999
Pagini: 252
Ilustrații: 14 Line drawings, black and white; 33 Tables, black and white; 14 Illustrations, black and white
Dimensiuni: 138 x 216 x 13 mm
Greutate: 0.45 kg
Ediția:1
Editura: Taylor & Francis
Colecția Routledge India
Seria Critical Political Economy of South Asia
Locul publicării:Oxford, United Kingdom
Public țintă
PostgraduateCuprins
1. Introduction 2. An Overview of Indian Pharmaceutical Industry and Health 3. Patterns of Trade in the Indian Pharmaceutical Industry 4. Pharmaceutical R&D in India 5. IPRs and Access to Medicines 6. The Drug Price Control System in India and Access to Medicines 7. Summary and Conclusion
Notă biografică
Reji K. Joseph is Associate Professor at the Institute for Studies in Industrial Development (ISID), New Delhi, India.
Recenzii
A timely well-researched contribution on the Indian pharmaceutical industry. Policymakers should take note of the concerns raised in respect of the impact of reforms on industrial development, innovation and access to medicines. — Dinesh Abrol, Institute for Studies in Industrial Development, New Delhi.
India's pharmaceutical industry is widely acknowledged as a success story but a major weakness is the import dependence on one country, China. Attracting our attention to this aspect which has important policy implications is one of the important merits of the book. — Sudip Chaudhuri, Indian Institute of Management Calcutta.
India's pharmaceutical industry is widely acknowledged as a success story but a major weakness is the import dependence on one country, China. Attracting our attention to this aspect which has important policy implications is one of the important merits of the book. — Sudip Chaudhuri, Indian Institute of Management Calcutta.
Descriere
This book explores the developments in the Indian pharmaceutical industry in the context of economic reforms introduced in India since 1991 and the implementation of the provisions in the TRIPS Agreement of the World Trade Organization. It also contains a comprehensive analysis of pharmaceutical export and import, research and development, access to medicines as well, as the latest drug price control system in the country.